Lupus & antiphospholipid syndrome
New efforts to incorporate patient-reported outcomes into lupus clinical trials: report of the community meeting convened by the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), 16–17 October 2024
Methodological detailspublic meeting, public-private partnership, small-group discussions
- Public meeting
- Public-private partnership
- Small-group discussions
Recommendations
As issued by the authors
Identify patient-reported outcome (PRO) measures appropriate for the target populations of interest
Incorporate PROs into endpoints for regulatory decision-making
Ensure PRO data are publicly available and accessible to researchers
Involve people living with lupus in selection of PRO domains, measures and trial design
Collaborations among industry, researchers, regulators, payors and patients are needed
Original publication
New efforts to incorporate patient-reported outcomes into lupus clinical trials: report of the community meeting convened by the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), 16–17 October 2024. Lupus Sci Med. Published 4 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →